Specialized in bioequivalence and analytical studies


AnaCipher Clinical Research Organization, a division of Indoco Remedies Ltd. is a Contract Research Organization specialized in bioequivalence and analytical studies. The state-of-the-art facility is spread over an area of 30,000 sq. ft. at Hyderabad, India, with capabilities to conduct bioavailability and bioequivalence studies, bioanalytical method development and validation, sample processing and analysis, statistical analysis and reporting. Read More

Updates

   Indoco's Clinical Research Organisation – AnaCipher receives accreditation from UKMHRA
  AnaCipher CRO receives BE study approval from NPRA-Malaysia in July 2021, through a desk assessment review process. The review process involved all the phases of the study.
  AnaCipher CRO receives BE study approval from WHO in March 2020, through a desk assessment review process. The review process involved the Clinical & Bio-analytical phases of the study.
   Indoco's CRO – AnaCipher receives EIR from USFDA
   Indoco's Clinical Research Organisation receives zero 483s from USFDA
   Indoco's CRO – ANACIPHER clears USFDA inspection with ZERO 483

Enquiry